170 related articles for article (PubMed ID: 35626181)
1. EPHA2, EPHA4, and EPHA6 Expression in Uveal Melanomas: Searching for the Culprits of Neoplasia.
Pergaris A; Danas E; Gajdzis P; Levidou G; Gajdzis M; Cassoux N; Gardrat S; Donizy P; Korkolopoulou P; Kavantzas N; Klijanienko J; Theocharis S
Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626181
[TBL] [Abstract][Full Text] [Related]
2. Expression Pattern and Prognostic Value of EPHA/EFNA in Breast Cancer by Bioinformatics Analysis: Revealing Its Importance in Chemotherapy.
Liang Z; Wang X; Dong K; Li X; Qin C; Zhou H
Biomed Res Int; 2021; 2021():5575704. PubMed ID: 33977106
[TBL] [Abstract][Full Text] [Related]
3. EPHA2, EPHA4, and EPHA7 Expression in Triple-Negative Breast Cancer.
Nikas I; Giaginis C; Petrouska K; Alexandrou P; Michail A; Sarantis P; Tsourouflis G; Danas E; Pergaris A; Politis PK; Nakopoulou L; Theocharis S
Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204461
[TBL] [Abstract][Full Text] [Related]
4. EphA4 is a prognostic factor in gastric cancer.
Miyazaki K; Inokuchi M; Takagi Y; Kato K; Kojima K; Sugihara K
BMC Clin Pathol; 2013 Jun; 13(1):19. PubMed ID: 23738943
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin-producing hepatocellular A6 overexpression is a novel biomarker of poor prognosis in patients with breast cancer.
Zhou D; Ren K; Wang J; Ren H; Yang W; Wang W; Li Q; Liu X; Tang F
Oncol Lett; 2018 Apr; 15(4):5257-5263. PubMed ID: 29552165
[TBL] [Abstract][Full Text] [Related]
6. Histone Deacetylase (HDAC)-1, -2, -4, and -6 in Uveal Melanomas: Associations with Clinicopathological Parameters and Patients' Survival.
Levidou G; Gajdzis P; Cassoux N; Donizy P; Masaoutis C; Gajdzis M; Gardrat S; Pergaris A; Danas E; Klijanienko J; Theocharis S
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638249
[TBL] [Abstract][Full Text] [Related]
7. [Expression of EphA2 in Metastatic and Non-Metastatic Primary Uveal Melanoma].
Vukoja V; Brandenbusch T; Tura A; Nassar K; Rohrbach DJ; Lüke M; Grisanti S; Lüke J
Klin Monbl Augenheilkd; 2016 Mar; 232(3):290-7. PubMed ID: 26854480
[TBL] [Abstract][Full Text] [Related]
8. The Clinical Impact of the EPH/Ephrin System in Cancer: Unwinding the Thread.
Pergaris A; Danas E; Goutas D; Sykaras AG; Soranidis A; Theocharis S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445116
[TBL] [Abstract][Full Text] [Related]
9. The EPH/Ephrin System in Gynecological Cancers: Focusing on the Roots of Carcinogenesis for Better Patient Management.
Psilopatis I; Pergaris A; Vrettou K; Tsourouflis G; Theocharis S
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328669
[TBL] [Abstract][Full Text] [Related]
10. Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors.
Noberini R; Koolpe M; Peddibhotla S; Dahl R; Su Y; Cosford ND; Roth GP; Pasquale EB
J Biol Chem; 2008 Oct; 283(43):29461-72. PubMed ID: 18728010
[TBL] [Abstract][Full Text] [Related]
11. Overexpressed gene signature of EPH receptor A/B family in cancer patients-comprehensive analyses from the public high-throughput database.
Phan NN; Liu S; Wang CY; Hsu HP; Lai MD; Li CY; Chen CF; Chiao CC; Yen MC; Sun Z; Jiang JZ
Int J Clin Exp Pathol; 2020; 13(5):1220-1242. PubMed ID: 32509099
[TBL] [Abstract][Full Text] [Related]
12. The Potential Role of Selected miRNA in Uveal Melanoma Primary Tumors as Early Biomarkers of Disease Progression.
Wróblewska JP; Lach MS; Ustaszewski A; Kulcenty K; Ibbs M; Jagiełło I; Suchorska WM; Marszałek A
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32131485
[TBL] [Abstract][Full Text] [Related]
13. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis.
van den Bosch T; van Beek JG; Vaarwater J; Verdijk RM; Naus NC; Paridaens D; de Klein A; Kiliç E
Invest Ophthalmol Vis Sci; 2012 May; 53(6):2668-74. PubMed ID: 22427574
[TBL] [Abstract][Full Text] [Related]
14. Ephrin Receptors (Ephs) Expression in Thymic Epithelial Tumors: Prognostic Implications and Future Therapeutic Approaches.
Masaoutis C; Georgantzoglou N; Sarantis P; Theochari I; Tsoukalas N; Bobos M; Alexandrou P; Pergaris A; Rontogianni D; Theocharis S
Diagnostics (Basel); 2021 Dec; 11(12):. PubMed ID: 34943502
[TBL] [Abstract][Full Text] [Related]
15. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
[TBL] [Abstract][Full Text] [Related]
16. High EIF4E2 expression is an independent prognostic risk factor for poor overall survival and recurrence-free survival in uveal melanoma.
Yang B; Gu A; Wu Y
Exp Eye Res; 2021 May; 206():108558. PubMed ID: 33785306
[TBL] [Abstract][Full Text] [Related]
17. The Expression Profile and Prognostic Values of EPHA Family Members in Breast Cancer.
Zhang X
Front Oncol; 2021; 11():619949. PubMed ID: 34221956
[TBL] [Abstract][Full Text] [Related]
18. Evolutionary Routes in Metastatic Uveal Melanomas Depend on
Rodrigues M; Mobuchon L; Houy A; Alsafadi S; Baulande S; Mariani O; Marande B; Ait Rais K; Van der Kooij MK; Kapiteijn E; Gassama S; Gardrat S; Barnhill RL; Servois V; Dendale R; Putterman M; Tick S; Piperno-Neumann S; Cassoux N; Pierron G; Waterfall JJ; Roman-Roman S; Mariani P; Stern MH
Clin Cancer Res; 2019 Sep; 25(18):5513-5524. PubMed ID: 31227496
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of High EphA1-4 Expression Levels in Locally Advanced Gastric Cancer.
Inokuchi M; Nakagawa M; Baogok N; Takagi Y; Tanioka T; Gokita K; Okuno K; Kojima K
Anticancer Res; 2018 Mar; 38(3):1685-1693. PubMed ID: 29491103
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of high mobility group A1 protein in human uveal melanomas: implication for prognosis.
Qu Y; Wang Y; Ma J; Zhang Y; Meng N; Li H; Wang Y; Wei W
PLoS One; 2013; 8(7):e68724. PubMed ID: 23935884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
